Evidence map›Paper›PMID 25591167›Full record

ArticleScientific reports2015

Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China.

Mingbin Liu, Xiaodan Li, Hui Yuan, Jianfang Zhou, Jingwen Wu, Hong Bo, Wen Xia, Ying Xiong, Lei Yang, Rongbao Gao and 26 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. RecombinantFrontiers in veterinary science · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors.

Mingbin LiuNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Xiaodan LiNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Hui YuanJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Jianfang ZhouNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Jingwen WuNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Hong BoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Wen XiaNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Ying XiongJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Lei YangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Rongbao GaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Junfeng GuoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Weijuan HuangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Ye ZhangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Xiang ZhaoNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Xiaohui ZouNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Tao ChenNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Dayan WangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Qun LiChinese Center for Disease Control and Prevention, Beijing, China, 102206.
ShiWen WangNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Shengen ChenNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Maohong HuNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Xiansheng NiNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Tian GongJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Yong ShiJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Jianxiong LiJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Jun ZhouJiangxi Provincial Disease Control and Prevention, Nanchang, China, 330029.
Jun CaiDonghu District Center for Disease Control and Prevention, Nanchang, China, 330008.
Zuke XiaoJiangxi Provincial people's Hospital, Nanchang, China, 330006.
Wei ZhangThe first affiliated hospital of Nanchang University, Nanchang, China, 330008.
Jian SunThe fourth affiliated hospital of Nanchang University, China, 330006.
Dexin LiNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Guizhen WuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.
Zijian FengChinese Center for Disease Control and Prevention, Beijing, China, 102206.
Yu WangChinese Center for Disease Control and Prevention, Beijing, China, 102206.
Haiying ChenNanchang Center for Disease Control and Prevention, Nanchang, China, 330038.
Yuelong ShuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, China, 102206.

Funding

DEVELOPING SUSTAINABLE INFLUENZA SURVEILLANCE NETWORKS AND RESPONSE TO AVIAN AND U51IP000334 · IP · NATL INST OF VIRAL DISEASE CONTROL/PREV · PI SHU, YUELONG · 2009 to 2013
$4.2M
NCIRD CDC HHS 5U51IP000334-03NCIRD CDC HHS U51 IP000334
6 · The paper itself

Abstract

Following the first human infection with the influenza A (H10N8) virus in Nanchang, China in December 2013, we identified two additional patients on January 19 and February 9, 2014. The epidemiologic, clinical, and virological data from the patients and the environmental specimen collected from 23 local live poultry markets (LPMs) were analyzed. The three H10N8 cases had a history of poultry exposure and presented with high fever (>38°C), rapidly progressive pneumonia and lymphopenia. Substantial high levels of cytokines and chemokines were observed. The sequences from an isolate (A/Environment/Jiangxi/03489/2013 [H10N8]) in an epidemiologically linked LPM showed highly identity with human H10N8 virus, evidencing LPM as the source of human infection. The HA and NA of human and environmental H10N8 isolates showed high identity (99.1-99.9%) while six genotypes with internal genes derived from H9N2, H7N3 and H7N9 subtype viruses were detected in environmental H10N8 isolates. The genotype of the virus causing human infection, Jiangxi/346, possessed a whole internal gene set of the A/Environment/Jiangxi/10618/2014(H9N2)-like virus. Thus, our findings support the notion that LPMs can act as both a gene pool for the generation of novel reassortants and a source for human infection, and intensive surveillance and management should therefore be conducted.

Indexed as

AgedAnimalsChemokinesChinaCytokinesFemaleGenotypeHemagglutininsHumansInfluenza A Virus, H10N8 SubtypeInfluenza A Virus, H7N3 SubtypeInfluenza A Virus, H7N9 SubtypeInfluenza A Virus, H9N2 SubtypeInfluenza, HumanInfluenza in BirdsMaleChemokinesCytokinesHemagglutininsNeuraminidase

Identifiers

PMID25591167
PMCPMC5379002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.